tiprankstipranks
Advertisement
Advertisement
Galmed Reports Fivefold Bioavailability Boost with New Aramchol Meglumine Oral Formulation
PremiumCompany AnnouncementsGalmed Reports Fivefold Bioavailability Boost with New Aramchol Meglumine Oral Formulation
1M ago
Galmed reports results from first-in-man PK study of Aramchol Meglumine
Premium
The Fly
Galmed reports results from first-in-man PK study of Aramchol Meglumine
1M ago
Galmed partnering with Tissue Dynamics to develop cardiac fibrosis platform
Premium
The Fly
Galmed partnering with Tissue Dynamics to develop cardiac fibrosis platform
1M ago
Galmed Unveils Brain-Penetrant Aramchol Formulation, Expanding Flagship Drug Into CNS Diseases
PremiumCompany AnnouncementsGalmed Unveils Brain-Penetrant Aramchol Formulation, Expanding Flagship Drug Into CNS Diseases
2M ago
Why Is Galmed Pharmaceuticals Stock (GLMD) Up Today?
Premium
Market News
Why Is Galmed Pharmaceuticals Stock (GLMD) Up Today?
2M ago
Galmed announces development of brain penetrating formulation of Aramchol
Premium
The Fly
Galmed announces development of brain penetrating formulation of Aramchol
2M ago
Galmed Pharmaceuticals’ Aramchol Study: Key Updates and Market Implications
PremiumCompany AnnouncementsGalmed Pharmaceuticals’ Aramchol Study: Key Updates and Market Implications
6M ago
Galmed Pharmaceuticals’ Aramchol Abstract Accepted for HEP-DART 2025 Presentation
Premium
Company Announcements
Galmed Pharmaceuticals’ Aramchol Abstract Accepted for HEP-DART 2025 Presentation
6M ago
Galmed Pharmaceuticals Secures New Patent for Aramchol Combination Therapy
Premium
Company Announcements
Galmed Pharmaceuticals Secures New Patent for Aramchol Combination Therapy
6M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100